Skip to main content

Advertisement

Table 1 Patient characteristics by study groups

From: Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand

Parameters cisplatin (N = 137) carboplatin (N = 76) P-value
Age (years) 51.6 (21–67) 53.8 (35–70) 0.051
Maximal diameter of primary tumor(cm) 4.5 (2–8) 4.3(2–9) 0.4
Stage    0.09
IIB 91(66.4 %) 43(56.6 %)
IIIA 0 2(2.6 %)
IIIB 44(32.1 %) 31(40.8 %)
IVA 2(1.5 %) 0
Pelvic Lymph nodes    0.63
No 72(52.6 %) 45(59.2 %)
Yes 14(10.2 %) 6(7.9 %)
Unknown 51(37.2 %) 25(32.9 %)
Histology    0.4
SCCA 114(83.2 %) 66(86.8 %)
ACA 21(15.3 %) 9(11.8 %)
Others 2(1.5 %) 1(1.3 %)
Histologic grade    0.66
1 18(14.8 %) 9(13.4 %)
2 78(63.9 %) 47(70.1 %)
3 26(21.3 %) 11(16.4 %)
Cycles    0.02
Up to 4 cycles 38 (27.7 %) 10(13.2 %)
5 to 6 cycles 99(72.3 %) 66(86.8 %)
Total treatment time (days) 56.8 (34–114) 56(43–173) 0.39
Median follow-up time (months) 39.8(6–69) 40.6(6–69) 0.76
  1. Note: SCCA squamous cell carcinoma, ACA adenocarcinoma